<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="3276">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 14, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04794400</url>
  </required_header>
  <id_info>
    <org_study_id>2020-07078</org_study_id>
    <nct_id>NCT04794400</nct_id>
  </id_info>
  <brief_title>Improved Oxygen Therapy in Covid-19</brief_title>
  <official_title>A Mask on Top of HFNC May Improve Oxygenation in Covid19</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Region Skane</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Region Skane</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients with severe respiratory failure due to Covid-19 are often treated with oxygen&#xD;
      through a high-flow nasal cannula (HFNC). We have made the clinical observation that the&#xD;
      oxygen levels in blood improves for some patients when a mask is applied on top of the HFNC.&#xD;
&#xD;
      This study aims to evaluate this intervention (applying a mask on top of HFNC)&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Baseline measurements will be taken without mask.&#xD;
&#xD;
      After 30 minutes with mask + HFNC, new measurements will be taken&#xD;
&#xD;
      30 minutes after mask removal, new measurements will be taken.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 4, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Oxygenation</measure>
    <time_frame>30 minutes</time_frame>
    <description>Change in SaO2 in % from ABG with mask vs without mask</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Carbon dioxide</measure>
    <time_frame>30 minutes</time_frame>
    <description>Change in PaCO2 in KPa from ABG with mask vs without mask</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SpO2</measure>
    <time_frame>60 minutes</time_frame>
    <description>Change in peripherally measured oxygen saturation before, with and after mask</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory rate</measure>
    <time_frame>30 minutes</time_frame>
    <description>Change in respiratory rate (breaths/min) with mask vs without mask</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective dyspnoea</measure>
    <time_frame>30 minutes</time_frame>
    <description>Change in subjective dyspnoea (Borg scale) with mask vs without mask</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PaO2</measure>
    <time_frame>30 minutes</time_frame>
    <description>PaO2 in Kpa from ABG with and without mask</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Covid19</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>oxygen mask</intervention_name>
    <description>an ordinary oxygen mask is applied over nose and mouth while participants maintain position and HFNC settings.</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Verified Covid19 infection&#xD;
&#xD;
          -  treatment with HFNC&#xD;
&#xD;
          -  Estimated P/F ratio of ≤ 13 KPa&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  language barrier&#xD;
&#xD;
          -  unable to provide consent&#xD;
&#xD;
          -  risk of deterioration due to study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gustav Torisson, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Region Skåne</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gustav Torisson, PhD</last_name>
    <phone>+4640337785</phone>
    <email>gustav.torisson@skane.se</email>
  </overall_contact>
  <location>
    <facility>
      <name>Skåne University Hospital</name>
      <address>
        <city>Malmö</city>
        <state>Skåne</state>
        <zip>20502</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gustav Torisson, PhD</last_name>
      <phone>+4640337785</phone>
      <email>gustav.torisson@skane.se</email>
    </contact>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>March 10, 2021</study_first_submitted>
  <study_first_submitted_qc>March 10, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 12, 2021</study_first_posted>
  <last_update_submitted>April 1, 2021</last_update_submitted>
  <last_update_submitted_qc>April 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Region Skane</investigator_affiliation>
    <investigator_full_name>Gustav Torisson</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

